Back
CareDx, Inc. 10K Form
Buy
77
CDNA
CareDx, Inc.
Last Price:
$18.92
Seasonality Move:
-9.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDNA News And Ratings
See the #1 stock for the next 7 days that we like better than CDNA
CDNA Financial Statistics
Sales & Book Value
| Annual Sales: | $333.8M |
|---|---|
| Cash Flow: | $35.4M |
| Price / Cash Flow: | 28.18 |
| Annual Sales: | $6.05 |
| Price / Book: | 3.06 |
Profitability
| EPS (TTM): | 1.19240 |
|---|---|
| Net Income (TTM): | $70.5M |
| Gross Margin: | $221.6M |
| Return on Equity: | 21.1% |
| Return on Assets: | 15% |
CareDx, Inc. Earnings Forecast
Key CareDx, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for CDNA is 66.40%.
-
The Selling, General & Administrative Expenses for CDNA have been equal to 61.57% of Gross Profit Margin.
-
The Research & Development expenses have been 21.69% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of CDNA is 15.74% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 7 years.
CareDx, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CDNA |
| CUSIP: | 14167L |
| Website: | caredx.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 3.03 |
| Quick Ratio: | 2.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.97 |
|---|---|
| Forward P/E Ratio: | 21.22 |
CDNA Technical Analysis vs Fundamental Analysis
Buy
77
CareDx, Inc. (CDNA)
is a Buy
Is CareDx, Inc. a Buy or a Sell?
-
CareDx, Inc. stock is rated a BuyThe current CareDx, Inc. [CDNA] share price is $18.90. The Score for CDNA is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.